February 26, 2026 Amidst Rare Disease Awareness Month, C-Path Shines a Light on Listening As a Form of Precision Medicine This perspective builds on insights shared during C-Path’s Global Impact Conference 2025 panel, “Ensuring a Focus on...”
February 25, 2026 View Now: Transforming Drug Development for Precision Medicines — A Practical Path from Evidence Generation to Reimbursement Critical Path Institute (C-Path) hosted this webinar on Wednesday February 25, that brought together...
February 25, 2026 C-Path Appoints Renowned Harvard Health Economist Amitabh Chandra to Board of Directors C-Path today announced the appointment of Amitabh Chandra, Ph.D., to its Board of Directors. Professor Chandra ...
February 20, 2026 What Collaboration Makes Possible On a Tuesday afternoon in the fall of 2019, a biostatistician from a pharmaceutical company...
February 16, 2026 Epilepsy disease classification: a community effort to enhance the Mondo Disease Ontology Epilepsy is a diverse group of neurological disorders affecting over 50 million people worldwide.
February 12, 2026 Building the Infrastructure of Hope Medical history is usually written as a chronicle of individual breakthroughs. We learn about Fleming discovering penicillin...
February 10, 2026 The Critical Path Institute Podcast: Electronic Clinical Outcome Assessments in Oncology Research This panel discussion, hosted by C-Path's Electronic Clinical Outcome Assessment Executive Director Scottie Kern...
February 6, 2026 Use of AI within COA linguistic validation and eCOA migration processes: analysis and good practice recommendations While there has been much discussion around the use of Artificial Intelligence (AI) for multilingual translations in other...
February 1, 2026 Turning the Impossible into the POSSIBLE February is Rare Disease Month. It is a time when the global community unites to support the 350 million people worldwide...
January 28, 2026 C-Path’s New Clinical Pharmacology & Therapeutics Publication Highlights Real-World Impact of FDA-Qualified Urine Biomarkers for Earlier Detection of Drug-Induced Kidney Injury C-Path's Predictive Safety Testing Consortium today announced the publication of a new peer-reviewed...